In mice, the inhibition of PDLIM2 resulted in increased lung cancer incidence and was reported to cause resistance against anticancer drugs and immunotherapeutic drugs, such as PD-1 inhibitor [17]. The gene discussed is PDLIM2; the disease is lung cancer.